Patent details
EP3720879
Title:
COMBINATION THERAPY BETWEEN ANTI-PROGASTRIN ANTIBODY AND IMMUNOTHERAPY TO TREAT CANCER
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
EP3720879
WO Application Number:
EP2018083651
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP18829742.8
WO Publication Number:
WO2019110662
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Luxembourg (LU)
Publications:
Dates
Filing date:
05/12/2018
Grant date:
11/05/2022
EP Publication Date:
14/10/2020
WO Publication Date:
13/06/2019
Claims Translations Received Date:
Claims Translation B1 Received Date:
14/07/2022
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/05/2022
EP B1 Publication Date:
11/05/2022
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
04/12/2038
Lapsed By Expiration Date:
Patent Validated Date:
21/07/2022
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
11/05/2022
Name:
Progastrine et Cancers S.à r.l.
Address:
11, Côte d'Eich, 1450 Luxembourg, Luxembourg (LU)
Agent
Name:
ir. F.A. Geurts c.s.
From:
20/07/2022
Address:
Octrooibureau Vriesendorp & Gaade B.V.
Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:
Inventor
Name:
PRIEUR, Alexandre
Address:
34000 Montpellier, France (FR)
Priority
Priority Patent Number:
201762594755 P
Priority Date:
05/12/2017
Priority Country:
United States of America (US)
Classification
IPC or IDT classification:
C07K 16/26 ;
C07K 16/28 ;
A61K 39/395 ;
Publication
Bulletin
1
Bulletin Heading:
EP3
Journal edition number:
30/22
Publication date:
27/07/2022
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
2
Bulletin Heading:
EP2
Journal edition number:
19/22
Publication date:
11/05/2022
Description:
European patents granted for the Netherlands
European Patent Bulletin
Issue number:
202219
Publication date:
11/05/2022
Description:
Grant (B1)
Annual Fee
Annual Fee(s) Due Date:
31/12/2025
Annual Fee Number:
8
Annual Fee Amount:
280 Euro
Last Annual Payment Date:
27/11/2024
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
220 Euro
Payer:
Acumass
Filing date
Document type
Document Description
Number of pages
File Type
20/07/2022
Outgoing Correspondence
Letter no formal defects
1
PDF
/1/1/7/2/9/0800792711/docs/ep18829742.8_1_494468l271.pdf
14/07/2022
Claims
First filed claims
2
PDF
/1/1/7/2/9/0800792711/docs/ep18829742.8_0_claims20220714164523392.pdf